Search results for: England
Filter search results
Invitation to OHE’s 2016 Annual Lecture with Dame Sally Davies: 10 Years of NIHR: Achievements and Challenges for the Next Decade – 7 November 2016
19 October 2016
…NIHR’s successes and challenges for the future. Professor Dame Sally Davies FRS FMedSci is Chief Medical Officer (CMO) for England and Chief Medical Advisor to the UK Government. Ten years…
OHE at ISPOR Europe 2016: Risk-sharing, Differential Pricing, the Cancer Drugs Fund, and Patient Reported Outcomes
26 October 2016
…Excellence (NICE) and were not routinely available within the NHS in England. After a consultation process, it was agreed that from July 2016, NICE will appraise all new licenced cancer…
New OHE Research Paper: The Distribution of the EQ-5D-5L Index in Patient Populations
1 November 2016
…Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust. For more information about OHE’s programme of EuroQol-related research,…
New OHE Research Paper: Uncertainty and Risk in HTA Decision Making
7 December 2016
…policy documents governing cost benefit analysis and cost effectiveness analysis in respect of HTA in England and Wales, and the results of interviews with former decision makers at the National…
OHE at HESG Winter 2017: Meet the Team
22 December 2016
…the EQ-5D-5L, Cambridgeshire Community Services NHS’s electronic patient records, and for the EQ-5D-3L data from the Health Survey for England 2014 and the NHS PROMs programme. In each case, we…
Invitation to OHE’s Annual Lecture 2017: Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe?
12 May 2017
…in Scotland and Northern Ireland and, to a lesser extent, in England and Wales over the same period. However, more robust progress against heart disease has – to date –…
Is There Societal Support for an End of Life Premium?
8 May 2017
…policy context in England, focusing on NICE’s appraisals of life-extending end of life treatments and recent changes to the Cancer Drugs Fund. He then presented the findings of a review…
OHE at HTAi 2017: Meet the Team
13 June 2017
…This study compares the availability and access to orphan medicinal products in the UK (England, Scotland and Wales), France, Germany, Italy and Spain. Orphan drugs are authorised in all EU…
Professor Dame Sally Davies: Ten Years of the NIHR: Achievements and Challenges for the Next Decade
15 June 2017
…in sequencing the human genome and translating the results into clinical practice. Dame Sally was appointed Chief Medical Officer for England and Chief Medical Advisor to the UK Government in…